PeopleBio

At a glance

PeopleBio filed 98 disclosures in the last 12 months, including 7 5% holder, 5 issuance, 2 m&a and 1 earnings. The most recent key filing was on Oct 8: A major holder's stake fell from 58.75% to 57.69% (conversion/exercise).

Revenue for 2025 was ₩2.9B, up 12.6% on 2024. It made an operating loss of ₩8.4B. Debt was 56% of equity at year end. The latest interim report (2026 H1) shows revenue of ₩2.3B and operating loss of ₩2.2B.

The 2025 annual report lists 43 employees with an average tenure of 6.4 years and average pay of ₩60.3M. Its 5 directors and auditors were paid ₩93M each on average. It paid no cash dividend for 2025. 강성민 and related parties held 13.28% at year end.

Of 2 recent 5%+ holder reports, 0 raised and 2 cut a stake; the largest stake reported was 57.69% on Oct 8.

From the 2025 annual report

Staff: 43 (18 men, 25 women), of whom 0 on fixed-term contracts. Total pay for the year: ₩2.9B. Directors and auditors: 5, paid ₩463M in total.

No cash dividend was paid for 2025.

Largest shareholder

강성민 holds 7.60%; with 8 related parties the group holds 13.28% of common shares at year end (from 13.41% at the start of the year).

Auditor: 다산회계법인 · opinion: Unqualified.

Source: 2025 annual business report (DART). How figures are combined

Financial summary

5%+ holder reports